The global infertility diagnostics devices market size is expected to grow at a CAGR of 8.80%, with Europe holding a significant market share during the forecast period of 2024-2032. The market is driven by the prevalence of infertility among couples, fuelled by factors such as delayed parenthood, lifestyle changes, and environmental influences in the region.
Key Takeaways
- Owing to technological improvements in diagnostic tools, including better imaging systems, sperm analysis techniques, and devices with artificial intelligence and machine learning integrated, the Europe infertility diagnostics devices market value is experiencing substantial growth. These developments are increasing the accuracy and efficacy of infertility diagnosis.
- The market is changing in favor of non-invasive, more individualized diagnostic options. Due to their ease of use and privacy, in-home fertility test kits are becoming more and more popular; however, non-invasive procedures are increasingly being chosen for diagnosis.
- The rising incidence of infertility in Europe can be attributed to a combination of changing lifestyles, environmental variables, and postponed parenthood. There is a greater need for infertility diagnosis tools due to a growing understanding and acceptance of reproductive problems and the range of diagnostic choices. Favorable reimbursement rules and the increase of fertility services are supporting this trend and driving the market's expansion.
Europe Infertility Diagnostics Devices Market Analysis
Infertility diagnostic devices are the tools used to assess and pinpoint the root causes of infertility in people or couples struggling to conceive. These tools leverage a variety of technologies, which includes kits that measure hormone levels, sperm quality and imaging devices that examine reproductive organs. There is a growing need for efficient diagnostic tools to support family planning and conception attempts due to the increasing prevalence of infertility.
Europe infertility diagnostics devices market demand is driven by multiple reasons, such as changing lifestyles, environmental conditions, and postponed childbearing. Such factors contribute to a greater incidence of infertility. The precision and effectiveness of diagnosing infertility are being improved by technological developments in diagnostics, including enhanced imaging systems and sperm analysis methods. More couples are seeking infertility testing, which can be attributed to increased awareness of reproductive problems and available diagnostic alternatives.
With multiple technological advancements, there has been an increased influx of new products and technologies. As a result, Europe infertility diagnostics devices market share is likely to augment in the forecast period. In October 2023, Caerus Biotech, a subsidiary of GryNumber Health Group, revolutionized male fertility diagnostics with a cutting-edge technology. The company launched a new sperm diagnostic device, MiOXSYS (Male Infertility Sperm Oxidative System), intended to provide clinicians with a quick and easy solution to assess oxidative stress levels. By measuring oxidation reduction potential (ORP), it helps in diagnosing infertility. Their focus is on addressing complex fertility challenges, particularly by exploring understudied factors to enhance patient outcomes.
Europe infertility diagnostics devices market growth is also driven by an increasing incidence of artificial intelligence-based startups in region. With nearly 1 in 6 adults worldwide experiencing infertility, the global fertility services market is projected to increase exponentially in the forecast period. However, existing solutions remain underfunded and inaccessible due to high costs and limited availability. AI technology is stepping in to address this gap with notable startups like Manina MedTech, a Spain based startup with an innovative solution called SEEDCHRONY. It calculates the optimal time for embryo transfer, significantly improving in vitro fertilization success rates. Sonio, on the other hand, is leveraging artificial intelligence to automate ultrasound reporting for prenatal screening, ensuring healthier pregnancies, and expanding the market share.
Europe Infertility Diagnostics Devices Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
- Equipment
- Media & Consumables
- Accessories
Market Breakup by Procedure
- In Vitro Fertilization
- Intracytoplasmic Sperm Injection
- Artificial Insemination
- Fertility Surgeries
- Others
Market Breakup by Patient Type
- Female
- Male
Market Breakup by Type
- Sperm Separation Devices
- Ovum Aspiration Pump
- Sperm Analyzer Systems
- Micromanipulator Systems
- Incubators
- Cryosystems
- Imaging Systems
- Microscope
- Others
Market Breakup by End User
- Hospitals & Surgical Clinics
- Cryobanks
- Research Institutes
- Others
Market Breakup by Countries
- United Kingdom
- Germany
- France
- Italy
- Others
Europe Infertility Diagnostics Devices Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cook Group
- Vitrolife
- Thermo Fisher Scientific
- Hamilton Thorne LTD
- Esco Micro Pte Ltd
- Genea Limited
- IVFtech APS
- FIJIFILM Irvine Scientific
- The Baker Company INC
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report
This product will be delivered within 5-7 business days.
Table of Contents
Companies Mentioned
- Cook Group
- Vitrolife
- Thermo Fisher Scientific Hamilton Thorne LTD
- Esco Micro Pte Ltd
- Genea Limited IVFtech APS
- FIJIFILM Irvine Scientific The Baker Company INC
Methodology
LOADING...
